Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred Tax AssetsLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eva Live (GOAI) Liabilities and Shareholders Equity (2021 - 2025)

Historic Liabilities and Shareholders Equity for Eva Live (GOAI) over the last 5 years, with Q3 2025 value amounting to $13.3 million.

  • Eva Live's Liabilities and Shareholders Equity rose 39192.1% to $13.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $32.8 million, marking a year-over-year increase of 15373.92%. This contributed to the annual value of $4.1 million for FY2024, which is 17815.81% up from last year.
  • Eva Live's Liabilities and Shareholders Equity amounted to $13.3 million in Q3 2025, which was up 39192.1% from $9.1 million recorded in Q2 2025.
  • Eva Live's 5-year Liabilities and Shareholders Equity high stood at $13.3 million for Q3 2025, and its period low was $1.5 million during Q4 2023.
  • Over the past 5 years, Eva Live's median Liabilities and Shareholders Equity value was $4.1 million (recorded in 2024), while the average stood at $5.0 million.
  • Its Liabilities and Shareholders Equity has fluctuated over the past 5 years, first plummeted by 3982.4% in 2023, then soared by 39192.1% in 2025.
  • Quarter analysis of 5 years shows Eva Live's Liabilities and Shareholders Equity stood at $3.5 million in 2021, then dropped by 29.17% to $2.5 million in 2022, then plummeted by 39.82% to $1.5 million in 2023, then soared by 178.16% to $4.1 million in 2024, then soared by 223.02% to $13.3 million in 2025.
  • Its Liabilities and Shareholders Equity was $13.3 million in Q3 2025, compared to $9.1 million in Q2 2025 and $6.3 million in Q1 2025.